Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. by Nzila, A, Ward, SA, Marsh, K, Sims, P, Hyde, J

Anticancer agents against malaria: time to revisit? by Nzila, A, Okombo, J, Becker, R, Chilengi, R, Lang, T, Niehues, T

Therapeutic potential of folate uptake inhibition in Plasmodium falciparum. by Nzila, A, Kokwaro, G, Winstanley, P, Marsh, K, Ward, SA

Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium. by Nzila, A, Ward, SA, Marsh, K, Sims, P, Hyde, J

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006. by Certain, L, Briceño, M, Kiara, S, Nzila, A, Watkins, WM, Sibley, C

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa. by Ochong, E, Nzila, A, Kimani, S, Kokwaro, G, Mutabingwa, T, Watkins, W, Marsh, K

In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum by Ommeh, S, Nduati, E, Mberu, E, Kokwaro, G, Marsh, K, Rosowsky, A, Nzila, A

Chemosensitization of Plasmodium falciparum by probenecid in vitro. by Nzila, A, Mberu, E, Bray, P, Kokwaro, G, Winstanley, P, Marsh, K, Ward, S

Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? by Nzila, A, Ochong, E, Nduati, E, Gilbert, K, Winstanley, P, Ward, S, Marsh, K

The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya. by Ochola-Oyier, L, Okombo, J, Mwai, L, Kiara, S, Pole, L, Tetteh, K, Nzila, A, Marsh, K

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. by Mwai, L, Kiara, S, Abdirahman, A, Pole, L, Rippert, A, Diriye, A, Bull, P, Marsh, K, Borrmann, S, Nzila, A

The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. by Ogutu, B, Nzila, A, Ochong, E, Mithwani, S, Wamola, B, Olola, C, Lowe, B, Kokwaro, G, Marsh, K, Newton, C

Chloroquine resistance before and after its withdrawal in Kenya. by Mwai, L, Ochong, E, Abdirahman, A, Kiara, S, Ward, S, Kokwaro, G, Sasi, P, Marsh, K, Borrmann, S, Mackinnon, M, Nzila, A

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax. by Imwong, M, Russell, B, Suwanarusk, R, Nzila, A, Leimanis, M, Sriprawat, K, Kaewpongsri, S, Phyo, A, Snounou, G, Nosten, F, Renia, L

TRANSPORTER GENES OTHER THAN PMDR1 AND PFCRT MAY ALTER THE RESPONSE OF PLASMODIUM FALCIPARUM TO LUMEFANTRINE by Mwai, L, Diriye, A, Masseno, V, Muriithi, S, Feltwell, T, Musyoki, J, Feller, A, Lemieux, J, Marsh, K, Newbold, C, Nzila, A, Carret, C

Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure. by Mwai, L, Diriye, A, Masseno, V, Muriithi, S, Feltwell, T, Musyoki, J, Lemieux, J, Feller, A, Mair, G, Marsh, K, Newbold, C, Nzila, A, Carret, C

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers. by Chilengi, R, Juma, R, Abdallah, A, Bashraheil, M, Lodenyo, H, Nyakundi, P, Anabwani, E, Salim, A, Mwambingu, G, Wenwa, E, Jemutai, J, Kipkeu, C, Oyoo, G, Muchohi, SN, Kokwaro, G, Niehues, T, Lang, T, Nzila, A

Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya by Borrmann, S, Straimer, J, Mwai, L, Abdi, A, Rippert, A, Okombo, J, Muriithi, S, Sasi, P, Kortok, M, Lowe, B, Campino, S, Assefa, S, Auburn, S, Manske, M, Maslen, G, Peshu, N, Kwiatkowski, D, Marsh, K, Nzila, A, Clark, T

PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation. by Preston, MD, Assefa, SA, Ocholla, H, Sutherland, C, Borrmann, S, Nzila, A, Michon, P, Hien, T, Bousema, T, Drakeley, C, Zongo, I, Ouédraogo, J, Djimde, A, Doumbo, O, Nosten, F, Fairhurst, R, Conway, D, Roper, C, Clark, T

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya by Wendler, J, Okombo, J, Amato, R, Miotto, O, Kiara, S, Mwai, L, Pole, L, O'Brien, J, Manske, M, Alcock, D, Drury, E, Sanders, M, Oyola, S, Malangone, C, Jyothi, D, Miles, A, Rockett, K, Macinnis, B, Marsh, K, Bejon, P, Nzila, A, Kwiatkowski, D